Gilead Sciences, Inc. today presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company's injectable HIV-1 capsid inhibitor, ...
That’s exactly the adventure awaiting you at 2nd Ave Thrift Superstore in Laurel, Maryland – a veritable Disneyland for the bargain-obsessed. Let me tell you something about thrift stores – they’re ...
Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases -- SCS Microinjector® Provides ...
Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of ...
8d
News-Medical.Net on MSNAdding chemotherapy to radiotherapy does not improve outcomes for cervical cancer patientsResults from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...
Local artists, including Nationals pitcher Cade Cavalli, designed custom ‘Curly W’ logos to be featured on Heritage Day ...
16dOpinion
MedPage Today on MSNWe're Getting the Medicaid Message Wrong — And It's Costing UsMedicaid serves lower-income adults, children, pregnant women, and people with disabilities, as well as dually-enrolled ...
1d
Creative Bloq on MSNThe history of the Tesla logo: from car badge to global tech brandLike many of the best car logos, the Tesla logo was originally conceived to look good on the front of vehicles, which it why ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on rare diseases, today announced that results from its Phase 2 FIGHT DMD clinical ...
1d
EssentiallySports on MSN“So Much Worse” – Nationals Face Fierce Backlash as Fans Reject Latest Uniform RevealA team's uniform is more than just fabric and thread; it's a symbol, a rallying cry, a visual representation of a city's ...
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today ...
IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results